2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow LT-002-158 Tablets: new trials by email Literature Review of LT-002-158 Tablets trials Research Report on LT-002-158 Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa LT-002-158 Tablets - Hidradenitis Suppurativa (HS) | Phase 1 / Phase 2 | Recruiting | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 12 | 2025-07-08 | 2026-08-27 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis LT-002-158 tablets - Atopic Dermatitis (AD) | Phase 1 / Phase 2 | Recruiting | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 24 | 2025-06-04 | 2026-08-27 |
Dermatitis, Atopic (1) · Hidradenitis Suppurativa (1)
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (2)
China (2)